Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780870 · ClinicalTrials.gov registry record · NA
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01780870 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT01780870, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet. The investigators will also study the following: 1. The impact of diet induced weight loss on hormones/adipokine levels 2. The impact of diet induced weight loss on leptin tolerance
Interventions
- DIETARY_SUPPLEMENT Weight loss group (Full meal replacement products)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01780870
The ClinicalTrials.gov registry entry for NCT01780870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Weight loss group (Full meal replacement products) is the first listed.
NCT01780870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01780870 about?
NCT01780870 is a clinical study titled "Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss". The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet. The investigators will also study the following:...
What is the current status of trial NCT01780870?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-09. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01780870?
The interventions under investigation include: Weight loss group (Full meal replacement products) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01780870?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.